n November 2020, the state of Oregon became the first U.S. state to both decriminalize psilocybin and also legalize it for therapeutic use. As of 2023, Oregonians will be able to apply to take psilocybin at a licensed facility with a trained supervisor. Will this help make psychedelics more widely available across the country? In this episode of The Economist’s “Checks and Balance” podcast, John Prideaux checks in with Jon Fasman and Charlotte Howard to discuss Oregon’s decriminalization of psychedelics and the promise of psychedelic therapy to transform health care.